ghk-cu dosage peptides Peptide Therapy: The Definitive Clinical Guide to Gene Modulation, Protocols, and Efficacy GHK-Cu Dosage: A Doctor's Guide

37 , 187204.e7 (2025)

Reduces inflammation and supports antioxidant defenses

BPC-157 is primarily a research compound Evidence quality : Both lack large human clinical trials, but GHK-Cu has more human data for skin applications Conclusion# BPC-157 and GHK-Cu serve complementary rather than competing roles in tissue healing research

The 15-residue linear sequence contains no cysteine residues, no disulfide constraints, and no unnatural amino acids, yet it maintains stability under conditions that would degrade nearly any other peptide of comparable size

The short plasma half-life of GHK-Cu is one reason why twice-daily dosing schedules are sometimes used in injectable protocols, though the peptide's downstream gene expression effects appear to persist well beyond its plasma clearance